Therapy-related acute myeloid leukemia is an unfortunate sequel to current multimodal intensive chemotherapy. The patient described was diagnosed with pure erythroleukemia, AML-M6b, during therapy for precursor B-cell acute lymphoblastic leukemia. To the best of our knowledge, this is the first report of this unusual association.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2350/11-04-1029-CR.1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!